Effect of roux-en-y gastric bypass on the NLRP3 Inflammasome in adipose tissue from obese rats

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Mocanu, Andreea Oana ^a,b   Mulya, Anny ^b   Huang, Hazel ^b   Dan, Olivia ^b   Shimizu, Hideharu ^b   Batayyah, Esam ^b   Brethauer, Stacy A ^b   Dinischiotu, Anca ^a   Kirwan, John P ^b  

^a UNIVERSITY OF BUCHAREST   (Romania)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS ASSOCIATED SPECK LIKE PROTEIN; CRYOPYRIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; GLUCOSE BLOOD LEVEL; NLRP3 PROTEIN, RAT;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; ASC GENE; BODY WEIGHT; CAPASE 1 GENE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC CORRELATION; GLUCOSE METABOLISM; GLYCEMIC CONTROL; IL 18 GENE; IL 1B GENE; IL 6 GENE; INTRAABDOMINAL FAT; MCP 1 GENE; MESENTERIC FAT; NLRP3 GENE; NONHUMAN; OBESITY; OMENTAL ADIPOSE TISSUE; ORAL GLUCOSE TOLERANCE TEST; PROTEIN EXPRESSION; RAT; REMISSION; ROUX Y ANASTOMOSIS; SHAM PROCEDURE; SUBCUTANEOUS FAT; TREATMENT OUTCOME; ANIMAL; GASTRIC BYPASS SURGERY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INFLAMMATION; MALE; METABOLISM; SPRAGUE DAWLEY RAT;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CARRIER PROTEINS; CASPASE 1; GASTRIC BYPASS; GLUCOSE TOLERANCE TEST; INFLAMMASOMES; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; OBESITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84947244779     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139764     Document Type: Article

References (37)

1. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011; 11 (2):98-107. doi: 10.1038/nri2925
2. Kanneganti TD, Ozören N, Body-Malapel M, Amer A, Park JH, Franchi L, et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature. 2006; 440(7081):233-6.
3. Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP, et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity. 2006; 24(3):317-27.
4. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 2006; 440(7081):228-32.
5. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010; 464(7293):1357-61. doi: 10.1038/nature08938
6. Aganna E, Hawkins PN, Ozen S, Pettersson T, Bybee A, McKee SA, et al. Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis. Genes Immun. 2004; 5(4):289-93.
7. Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-Associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006; 440(7081):237-41.
8. Pétrilli V, Dostert C, Muruve DA, Tschopp J. The inflammasome: A danger sensing complex triggering innate immunity. Curr Opin Immunol. 2007; 19(6):615-22.
9. Wilmanski JM, Petnicki-Ocwieja T, Kobayashi KS. NLR proteins: integral members of innate immunity and mediators of inflammatory diseases. J Leukoc Biol. 2008; 83(1):13-30.
10. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010; 11(2):136-40. doi: 10.1038/ni.1831
11. Stienstra R, Joosten LA, Koenen T, van Tits B, van Diepen JA, van den Berg SA, et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 2010; 12(6):593-605. doi: 10.1016/j.cmet.2010.11.011
12. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011; 17(2):179-88. doi: 10.1038/nm.2279
13. Moschen AR, Molnar C, Enrich B, Geiger S, Ebenbichler CF, Tilg H. Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss. Mol Med. 2011; 17(7-8):840-5. doi: 10.2119/molmed.2010.00108
14. García de la Torre N, Rubio MA, Bordiu E, Cabrerizo L, Aparicio E, Hernández C, et al. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin. J Clin Endocrinol Metab. 2008; 93(11):4276-81. doi: 10.1210/jc.2007-1370
15. Konukoglu D, Uzun H, Firtina S, Cigdem Arica P, Kocael A, Taskin M. Plasma adhesion and inflammation markers: Asymmetrical dimethyl-L-Arginine and secretory phospholipase A2 concentrations before and after laparoscopic gastric banding in morbidly obese patients. Obes Surg. 2007; 17(5):672-8.
16. Sturm W, Tschoner A, Engl J, Kaser S, Laimer M, Ciardi C, et al. Effect of bariatric surgery on both functional and structural measures of premature atherosclerosis. Eur Heart J. 2009; 30(16):2038-43. doi: 10.1093/eurheartj/ehp211
17. Vázquez LA, Pazos F, Berrazueta JR, Fernández-Escalante C, García-Unzueta MT, Freijanes J, et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2005; 90(1):316-22.
18. Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care. 2008; 31 Suppl 2:S290-6. doi: 10.2337/dc08-s271
19. Couzin J. Medicine. Bypassing medicine to treat diabetes. Science. 2008; 320(5875):438-40. doi: 10.1126/science.320.5875.438
20. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: A randomized controlled trial. JAMA. 2008; 299 (3):316-23. doi: 10.1001/jama.299.3.316
21. Gatmaitan P, Huang H, Talarico J, Moustarah F, Kashyap S, Kirwan JP, et al. Pancreatic islet isolation after gastric bypass in a rat model: Technique and initial results for a promising research tool. Surg Obes Relat Dis. 2010; 6(5):532-7. doi: 10.1016/j.soard.2010.05.018
22. Meguid MM, Ramos EJ, Suzuki S, Xu Y, George ZM, Das UN, et al. A surgical rat model of human Roux-en-Y gastric bypass. J Gastrointest Surg. 2004; 8(5):621-30.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25(4):402-8.
24. Zoico E, Di Francesco V, Mazzali G, Vettor R, Fantin F, Bissoli L, et al. Adipocytokines, fat distribution, and insulin resistance in elderly men and women. J Gerontol A Biol Sci Med Sci. 2004; 59(9):M935-9.
25. Alvehus M, Burén J, Sjöström M, Goedecke J, Olsson T. The human visceral fat depot has a unique inflammatory profile. Obesity (Silver Spring). 2010; 18(5):879-83.
26. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: A systematic review and meta-Analysis. JAMA. 2004; 292(14):1724-37.
27. Esposito K, Giugliano G, Scuderi N, Giugliano D. Role of adipokines in the obesity-inflammation relationship: The effect of fat removal. Plast Reconstr Surg. 2006; 118(4):1048-57; discussion 58-9.
28. Habib P, Scrocco JD, Terek M, Vanek V, Mikolich JR. Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis. Am J Cardiol. 2009; 104(9):1251-5. doi: 10.1016/j.amjcard.2009.06.042
29. Sledzinski T, Sledzinski M, Smolenski RT, Swierczynski J. Increased serum nitric oxide concentration after bariatric surgery-A potential mechanism for cardiovascular benefit. Obes Surg. 2010; 20(2):204-10. doi: 10.1007/s11695-009-0041-2
30. Moschen AR, Molnar C, Geiger S, Graziadei I, Ebenbichler CF, Weiss H, et al. Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut. 2010; 59(9):1259-64. doi: 10.1136/gut.2010.214577
31. Laimer M, Ebenbichler CF, Kaser S, Sandhofer A, Weiss H, Nehoda H, et al. Markers of chronic inflammation and obesity: A prospective study on the reversibility of this association in middle-Aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord. 2002; 26(5):659-62.
32. Ashrafian H, le Roux CW, Darzi A, Athanasiou T. Effects of bariatric surgery on cardiovascular function. Circulation. 2008; 118(20):2091-102. doi: 10.1161/CIRCULATIONAHA.107.721027
33. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005; 54(8):2277-86.
34. Kováčiková M, Sengenes C, Kováčová Z, Siklová-Vítková M, Klimčáková E, Polák J, et al. Dietary intervention-induced weight loss decreases macrophage content in adipose tissue of obese women. Int J Obes (Lond). 2011; 35(1):91-8.
35. Yin D, Gao Q, Ma LL, Yan W, Williams P, Wasserman D, et al. Bariatric surgery regulates tissue specific inflammation in high fat diet-induced obese mice. The Journal of Immunology. 2011; 186, 50.14.
36. Poulain-Godefroy O, Le Bacquer O, Plancq P, Lecoeur C, Pattou F, Fröhbeck G, et al. Inflammatory role of Toll-like receptors in human and murine adipose tissue. Mediators Inflamm. 2010; 2010:823486. doi: 10.1155/2010/823486
37. Bradley D, Conte C, Mittendorfer B, Eagon JC, Varela JE, Fabbrini E, et al. Gastric bypass and banding equally improve insulin sensitivity and β cell function. J Clin Invest. 2012; 122(12):4667-74. doi: 10. 1172/JCI64895